Pavement Burns | NEJM
A 56-year-old man was transferred to a burn center for management of pavement burns on his feet that had occurred during a heat wave.
Related Articles
Tolebrutinib versus Teriflunomide in Multiple Sclerosis | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Tolebrutinib versus Teriflunomide in Multiple Sclerosis
Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation | NEJM
Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of heart-failure admission among high-risk patients. However, most patients with valvular heart disease, including those undergoing…
Nerandomilast in Patients with Progressive Pulmonary Fibrosis | NEJM
Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory properties. Nerandomilast has been shown to slow the progr…
An Evidence-Based Approach to Covid-19 Vaccination | NEJM
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
As-Needed Albuterol–Budesonide in Mild Asthma | NEJM
As-needed use of albuterol–budesonide has been shown to result in a significantly lower risk of severe asthma exacerbation than as-needed use of albuterol alone among…
An Evidence-Based Approach to Covid-19 Vaccination | NEJM
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
An Evidence-Based Approach to Covid-19 Vaccination | NEJM
This article from the FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and announces the adoption of an evidence-based approach…
Treatment of Pyelonephritis | NEJM
EFFECTIVE therapy for most bacterial infections has been developed since the advent of potent antimicrobial agents. Chronic pyelonephritis, however, has been notably refractory to permanent…
Smoldering Multiple Myeloma | NEJM
MULTIPLE myeloma is characterized by an increase of abnormal plasma cells in the bone marrow and monoclonal protein in the serum, often with osteolytic bone…
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis | NEJM
Nerandomilast (BI 1015550) is an orally administered preferential inhibitor of phosphodiesterase 4B with antifibrotic and immunomodulatory effects. In a phase 2 trial involving patients with…